MONTHLY IBANDRONATE REDUCES BONE LOSS IN OSTEOPENIC WOMEN WITH RHEUMATOID ARTHRITIS RECEIVING LONG-TERM GLUCOCORTICOIDS: A 48-WEEK DOUBLE-BLINDED RANDOMIZED PLACEBO-CONTROLLED INVESTIGATOR-INITIATED TRIAL

被引:0
|
作者
Shin, K. [1 ]
Park, S. -H. [2 ]
Park, W. [3 ]
Baek, H. -J. [4 ]
Lee, Y. -J. [5 ]
Kang, S. -W. [6 ]
Choe, J. -Y. [7 ]
Yoo, W. -H. [8 ]
Park, Y. -B. [9 ]
Song, J. -S. [10 ]
Yoo, B. [11 ]
Yoo, D. -H. [12 ]
Song, Y. W. [13 ]
机构
[1] SMG SNU Boramae Med Ctr, Div Rheumatol, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Div Rheumatol, Seoul, South Korea
[3] Inha Univ Hosp, Div Rheumatol, Incheon, South Korea
[4] Gachon Univ, Gil Med Ctr, Div Rheumatol, Incheon, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Div Rheumatol, Bundang, South Korea
[6] Chungnam Natl Univ Hosp, Div Rheumatol, Daejeon, South Korea
[7] Daegu Catholic Univ, Med Ctr, Div Rheumatol, Daegu, South Korea
[8] Chonbuk Natl Univ Hosp, Div Rheumatol, Jeonju, South Korea
[9] Yonsei Univ, Severance Hosp, Coll Med, Div Rheumatol, Seoul, South Korea
[10] Chung Ang Univ Hosp, Div Rheumatol, Seoul, South Korea
[11] Univ Ulsan, Coll Med, Asan Med Ctr, Div Rheumatol, Seoul, South Korea
[12] Hanyang Univ, Med Ctr, Div Rheumatol, Seoul, South Korea
[13] Seoul Natl Univ Hosp, Div Rheumatol, Seoul, South Korea
关键词
D O I
10.1136/annrheumdis-2015-eular.3204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0286
引用
收藏
页码:762 / 762
页数:1
相关论文
共 26 条
  • [1] Monthly Ibandronate Reduces Bone Loss in Osteopenic Women with Rheumatoid Arthritis Receiving Long-Term Glucocorticoids: A 48-Week Double-Blinded Randomized Placebo-Controlled Investigator-Initiated Trial
    Shin, Kichul
    Park, Sung-Hwan
    Park, Won
    Baek, Han Joo
    Lee, Yun Jong
    Kang, Seong-Wook
    Choe, Jung-Yoon
    Yoo, Wan-Hee
    Park, Yong-Beom
    Song, Jung-Soo
    Yoo, Bin
    Yoo, Dae-Hyun
    Song, Yeong Wook
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (12) : 3535 - 3535
  • [2] Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial
    Shin, Kichul
    Park, Sung-Hwan
    Park, Won
    Baek, Han Joo
    Lee, Yun Jong
    Kang, Seong Wook
    Choe, Jung-Yoon
    Yoo, Wan-Hee
    Park, Yong-Beom
    Song, Jung-Soo
    Lee, Seung-Geun
    Yoo, Bin
    Yoo, Dae-Hyun
    Song, Yeong Wook
    CLINICAL THERAPEUTICS, 2017, 39 (02) : 268 - 278
  • [3] Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial
    C.-L. Shen
    S. Yang
    M. D. Tomison
    A. W. Romero
    C. K. Felton
    H. Mo
    Osteoporosis International, 2018, 29 : 881 - 891
  • [4] Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial
    Shen, C-L
    Yang, S.
    Tomison, M. D.
    Romero, A. W.
    Felton, C. K.
    Mo, H.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (04) : 881 - 891
  • [5] A 48-week Randomized double-blind double-observer placebo-controlled multicentre trial of intramuscular gold in combination with methotrexate in rheumatoid arthritis.
    Lehman, AJ
    Esdaile, JM
    Klinkhoff, A
    Schulzer, M
    Grant, E
    Fitzgerald, A
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S204 - S205
  • [6] Risedronate for prevention of bone loss in patients receiving high dose corticosteroids: A 6-month randomized double-blinded placebo-controlled trial
    Mok, C. C.
    Tong, K. H.
    To, C. H.
    Siu, Y. P.
    Yu, K. L.
    Ma, K. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 101 - 102
  • [7] LONG-TERM VASODILATOR THERAPY OF CHRONIC AORTIC-INSUFFICIENCY - A RANDOMIZED DOUBLE-BLINDED, PLACEBO-CONTROLLED CLINICAL-TRIAL
    GREENBERG, B
    MASSIE, B
    BRISTOW, JD
    CHEITLIN, M
    SIEMIENCZUK, D
    TOPIC, N
    WILSON, RA
    SZLACHCIC, J
    THOMAS, D
    CIRCULATION, 1988, 78 (01) : 92 - 103
  • [8] Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial
    M P van der Aa
    M A J Elst
    E M W van de Garde
    E G A H van Mil
    C A J Knibbe
    M M J van der Vorst
    Nutrition & Diabetes, 2016, 6 : e228 - e228
  • [9] Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial
    van der Aa, M. P.
    Elst, M. A. J.
    van de Garde, E. M. W.
    van Mil, E. G. A. H.
    Knibbe, C. A. J.
    van der Vorst, M. M. J.
    NUTRITION & DIABETES, 2016, 6 : e228 - e228
  • [10] Long-term antibiotic treatment in reactive arthritis (ReA) and undifferentiated oligoarthritis (UOA): Results of a double-blinded placebo-controlled randomized study
    Sieper, J
    Fendler, C
    Eggens, U
    Laitko, S
    Sorensen, H
    Keitel, W
    Hiepe, F
    Braun, J
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1178 - 1178